fos
Compounds containing phosphorus, many of them pesticides or worm treatments.
- Drugs containing fos: 42
- Approved somewhere: 12
- With a US drug page: 10
- Stem
- fos
- Class
- Compounds containing phosphorus, many of them pesticides or worm treatments
- Sub-stems
- -fosfamide, -fosine, -vos
- Most common targets
- DNA (5), TACR1 (2), POL (1), DNA polymerase catalytic subunit (1), MURA (1), ACE (1), Sodium channel alpha subunit (1), SYK (1)
Approved and clinical-stage drugs in ChEMBL whose names containing fos or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Fosamprenavir | Approved | POL | Human immunodeficiency virus type 1 protease inhibitor |
| Foscarnet | Approved | DNA polymerase catalytic subunit | Human herpesvirus 1 DNA polymerase inhibitor |
| Fosdenopterin | Approved | — | Unknown |
| Fosfomycin | Approved | MURA | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor |
| Fosinopril | Approved | ACE | Angiotensin-converting enzyme inhibitor |
| Fosphenytoin | Approved | Sodium channel alpha subunit | Sodium channel alpha subunit blocker |
| Fostamatinib | Approved | SYK | Tyrosine-protein kinase SYK inhibitor |
| Fospropofol | Phase 3 | — | Unknown |
| Fosaprepitant | Approved | TACR1 | Neurokinin 1 receptor antagonist |
| Fosnetupitant | Approved | TACR1 | Neurokinin 1 receptor antagonist |
| Fostemsavir | Approved | ENV | Envelope polyprotein GP160 inhibitor |
| Fosbretabulin | Phase 3 | Tubulin | Tubulin inhibitor |
| Fosfocreatine | Phase 3 | — | — |
| Fosgemcitabine palabenamide | Phase 3 | — | — |
| Foslevodopa | Phase 3 | ADRB1 | Beta-1 adrenergic receptor agonist |
| Fosmanogepix | Phase 3 | GWT1 | GPI-anchored wall transfer protein 1 inhibitor |
| Fosmetpantotenate | Phase 3 | — | Phosphopantothenate replacement therapy |
| Fosmidomycin | Phase 3 | DXR | 1-deoxy-D-xylulose 5-phosphate reductoisomerase, apicoplastic inhibitor |
| Fosclevudine alafenamide | Phase 2 | — | — |
| Fosdagrocorat | Phase 2 | NR3C1 | Glucocorticoid receptor modulator |
| Fosdesdenosine sipalabenamide | Phase 2 | — | — |
| Foselutoclax | Phase 2 | — | — |
| Fosgonimeton | Phase 2 | — | — |
| Fosigotifator | Phase 2 | — | — |
| Foslinanib | Phase 2 | — | — |
| Fosravuconazole | Phase 2 | ERG11 | Cytochrome P450 51 inhibitor |
| Foscarbidopa | Phase 1 | DDC | DOPA decarboxylase inhibitor |
| Fosciclopirox | Phase 1 | — | — |
| Fosifloxuridine nafalbenamide | Phase 1 | — | — |
| Fostroxacitabine bralpamide | Phase 1 | — | — |
| Fosfonet | — | — | — |
| Ifosfamide | Approved | DNA | DNA inhibitor |
| Canfosfamide | Phase 3 | DNA | DNA disrupting agent |
| Glufosfamide | Phase 3 | DNA | DNA disrupting agent |
| Palifosfamide | Phase 3 | DNA | DNA cross-linking agent |
| Trofosfamide | Phase 3 | — | — |
| Evofosfamide | Phase 2 | DNA | DNA inhibitor |
| Perfosfamide | Phase 2 | — | — |
| Mafosfamide | Phase 1 | — | — |
| Miltefosine | Approved | — | Unknown |
| Perifosine | Phase 3 | — | — |
| Iopofosine | Phase 2 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO